Stapley Marc, CEO, reported a transaction classified as grant at VERACYTE, INC. involving 67277.000000 shares for an estimated $0.00. Reported holdings after the transaction were 375329.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
Stored Form 4 columns with their raw values
Badges describe filing facts only — not predictions.
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
Form 4 relationship flags and nearby filing context
Chief Executive Officer
Represents shares of common stock acquired by the Reporting Person upon vesting of certain performance based restricted stock units ("PSUs") on February 27, 2025, upon the certification by the Board o…
Includes 707 shares of common stock purchased on January 31, 2025 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan.
Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of the PSUs and does not represent a sale.
The reporting person is reporting the withholding of 1,486, 1,795, 2,478 and 14,565 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting…
2,925, 3,533, 4,878 and 28,681 Restricted Stock Units granted on June 1, 2021, March 3, 2022, March 6, 2023 and March 6, 2024, respectively, and does not represent a sale by the reporting person.
0 other filings
0 recent txs